Rankiteo Logo
Rankiteo
Leader in Cyber Underwriting
Loading...
NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop
WindowsmacOSLinux
Download

Comparison Overview

Novartis DeutschlandNovartis Deutschland
VS
SanofiSanofi
Novartis Deutschland

Novartis Deutschland

Sophie-Germain Straße 10, Nürnberg, Bayern, 90443, DE

Last Update: 29/12/2025

View Profile
Between 750 and 799
http://www.novartis.de
756/1000Fair

Novartis ist ein führendes Pharmaunternehmen in Deutschland mit ca. 2.600 Mitarbeitenden an verschiedenen Standorten und mehr als 70.000 Mitarbeitenden weltweit. Wir sind angetrieben davon, Medizin neu zu denken, um das Leben von Menschen zu verbessern. Wir nutzen Wisse...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:442
Subsidiaries:43
12-month incidents
0
Known data breaches
0
Attack type number
0
Sanofi

Sanofi

46 Avenue de la Grande-Armée, Paris, France, FR, 75017

Last Update: 20/05/2026

View Profile
Between 800 and 849
http://www.sanofi.com
824/1000Good

We are an R&D driven, AI-powered biopharma company committed to improving people’s lives and delivering compelling growth. We apply our deep understanding of the immune system to invent medicines and vaccines that treat and protect millions of people around the world,...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:91,571
Subsidiaries:5
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Ranges Comparison

Based On Specific Ai Models Category
Novartis Deutschland

Novartis Deutschland

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA
Sanofi

Sanofi

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA

Benchmark & Cyber Underwriting Signals

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Novartis Deutschland in 2026.

Incidents

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Sanofi in 2026.

Incidents

Incident History - Novartis Deutschland (X = Date, Y = Severity)

Novartis Deutschland cyber incidents detection timeline including parent company and subsidiaries.

R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Incident History - Sanofi (X = Date, Y = Severity)

Sanofi cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Notable Incidents

Last Cyber / HR Incidents / Global...
Novartis Deutschland

Novartis Deutschland

Incidents
No explicit notable incidents reported.
Sanofi

Sanofi

Incidents
No explicit notable incidents reported.

FAQ

Between Novartis Deutschland company and Sanofi company, which one has the best AI Cybersecurity Score ?
Between Novartis Deutschland company and Sanofi company, which one has experienced more cyber incidents in the past ?
Between Novartis Deutschland company and Sanofi company, which one has experienced more cyber incidents this year ?
Between Novartis Deutschland company and Sanofi company, which one has experienced at least one ransomware attack ?
Between Novartis Deutschland company and Sanofi company, which one has experienced at least one data breach ?
Between Novartis Deutschland company and Sanofi company, which one has experienced at least one targeted cyberattack ?
Between Novartis Deutschland company and Sanofi company, which one has experienced at least one vulnerability ?
Between Novartis Deutschland company and Sanofi company, which one holds the most compliance certifications ?
Between Novartis Deutschland company and Sanofi company, which one holds the fewest compliance certifications ?
Between Novartis Deutschland company and Sanofi company, which one has the most subsidiaries ?
Between Novartis Deutschland company and Sanofi company, which one has the largest number of employees ?
Between Novartis Deutschland and Sanofi, which company holds both SOC 2 Type 1 certifications ?
Between Novartis Deutschland and Sanofi, which company holds both SOC 2 Type 2 certifications ?
Which company is ISO 27001 certified - Novartis Deutschland or Sanofi ?
Which company is PCI DSS compliant - Novartis Deutschland or Sanofi ?
Between Novartis Deutschland and Sanofi, which company complies with HIPAA regulations for healthcare data ?
Between Novartis Deutschland and Sanofi, which company complies with GDPR requirements ?

Latest Global CVEs

CVE-2026-59723
SUMMARY

Cline is an autonomous coding agent as an SDK, IDE extension, or CLI assistant. Prior to 3.0.30, the Cline Hub dashboard server launched by the cline dashboard command accepts WebSocket connections on the /browser endpoint without validating the Origin header, and when ROOM_SECRET is unset for local 127.0.0.1 binds, isAuthorizedBrowserRequest() allows attacker-controlled websites to send desktopCommand frames that read workspace state, mutate MCP and provider settings, and trigger command execution when a provider or model is configured. This issue is fixed in version 3.0.30.

PUBLISHED
Date2026-07-08
UPDATED
Date2026-07-08
RISK INFORMATION (Score: 8.8)
CVSS3
Base Score: 8.8
Complexity: LOW
CVSS:3.1/AV:A/AC:L/PR:N/UI:R/S:C/C:H/I:H/A:H
IMPACT SCORE
6
EXPLOITABILITY
2.1
CVE-2026-54784
SUMMARY

CoreWCF is a port of the service side of Windows Communication Foundation (WCF) to .NET Core. In version 1.9.0, CoreWCF SPNEGO SecurityContextToken negotiation can expose the proof key recovered from the RSTR when TransportWithMessageCredential with Windows client credentials and session establishment are used, allowing an observer to impersonate the authenticated Windows principal and decrypt or forge WS-SecureConversation traffic. This issue is fixed in version 1.9.1.

PUBLISHED
Date2026-07-08
UPDATED
Date2026-07-08
RISK INFORMATION (Score: 7.4)
CVSS3
Base Score: 7.4
Complexity: HIGH
CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:U/C:H/I:H/A:N
IMPACT SCORE
5.2
EXPLOITABILITY
2.2
CVE-2026-54783
SUMMARY

CoreWCF is a port of the service side of Windows Communication Foundation (WCF) to .NET Core. Prior to 1.8.1 and 1.9.1, CoreWCF WS-Security endorsing and supporting signature verification does not ensure the selected ds:Signature covers the expected Security header target, allowing an attacker with one captured signed SOAP envelope to replay arbitrary service operations as the victim principal. This issue is fixed in versions 1.8.1 and 1.9.1.

PUBLISHED
Date2026-07-08
UPDATED
Date2026-07-08
RISK INFORMATION (Score: 7.4)
CVSS3
Base Score: 7.4
Complexity: HIGH
CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:U/C:H/I:H/A:N
IMPACT SCORE
5.2
EXPLOITABILITY
2.2
CVE-2026-54782
SUMMARY

CoreWCF is a port of the service side of Windows Communication Foundation (WCF) to .NET Core. Prior to 1.8.1 and 1.9.1, CoreWCF SAML 1.1 and SAML 2.0 token validation does not correctly resolve the issuer signing key or require signed tokens when IdentityConfiguration is used with federated bindings, allowing an unauthenticated remote attacker to impersonate any principal the trusted STS could issue. This issue is fixed in versions 1.8.1 and 1.9.1.

PUBLISHED
Date2026-07-08
UPDATED
Date2026-07-08
RISK INFORMATION (Score: 10)
CVSS3
Base Score: 10.0
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:C/C:H/I:H/A:N
IMPACT SCORE
5.8
EXPLOITABILITY
3.9
CVE-2026-54781
SUMMARY

CoreWCF is a port of the service side of Windows Communication Foundation (WCF) to .NET Core. Prior to 1.8.1 and 1.9.1, CoreWCF SAML token validation does not enforce SubjectConfirmation method URIs or holder-of-key proof keys in SamlSecurityTokenHandler, allowing holder-of-key downgrade or custom confirmation method assertions to authenticate a subject without proving authority over the assertion. This issue is fixed in versions 1.8.1 and 1.9.1.

PUBLISHED
Date2026-07-08
UPDATED
Date2026-07-08
RISK INFORMATION (Score: 7.4)
CVSS3
Base Score: 7.4
Complexity: HIGH
CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:U/C:H/I:H/A:N
IMPACT SCORE
5.2
EXPLOITABILITY
2.2